Stock GPCR STRUCTURE THERAPEUTICS INC.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Structure Therapeutics Inc.

Equities

GPCR

US86366E1064

Market Closed - Nasdaq
Other stock markets
 16:00:00 2024-06-06 EDT 		5-day change 1st Jan Change
55.63 USD -1.19% Intraday chart for Structure Therapeutics Inc. +64.78% +36.48%
06-06 Structure Therapeutics Prices Upsized $476 Million Stock Offering MT
06-03 Structure Therapeutics Plans Offering of American Depositary Shares MT

Evolution of the average Target Price on Structure Therapeutics Inc.

Price target over the last 5 years

History of analyst recommendation changes

e3b242fc231c35e1.DwhK3qmmZsI-2jhHCzineKuhxHVO7cdoLZ17Mr9uJEM.QEUw7efoMY1ytFp2SnbuTPSSrAR7wKkheswrfIwGRm5-SgGU3-VQk2HvcQ~6c207230f10835e62744e4a3606892e3

Analyst Recommendations on Structure Therapeutics Inc.

JPMorgan Starts Structure Therapeutics With Overweight Rating MT
Cantor Fitzgerald Initiates Structure Therapeutics at Overweight Rating With $65 Price Target MT
JMP Securities Adjusts Structure Therapeutics' Price Target to $91 From $90, Keeps Market Outperform Rating MT
Piper Sandler Raises Price Target on Structure Therapeutics to $93 From $58, Maintains Overweight Rating MT
JMP Securities Starts Coverage on Structure Therapeutics with Market Outperform Rating, $90 Price Target MT
BMO Capital Adjusts Structure Therapeutics Price Target to $83 From $40, Maintains Outperform Rating MT
Piper Sandler Initiates Structure Therapeutics With Overweight Rating, $58 Price Target MT
SVB Securities Initiates Structure Therapeutics at Outperform Rating With $33 Price Target MT
BMO Capital Initiates Structure Therapeutics at Outperform With $40 Price Target MT
Jefferies Initiates Structure Therapeutics at Buy With $34 Price Target MT
Guggenheim Starts Structure Therapeutics at Buy With $50 Price Target MT
Analysis-Biotech IPOs to bloom with spotlight on startups with human trial data RE
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
10
Last Close Price
55.63 USD
Average target price
83.1 USD
Spread / Average Target
+49.38%
High Price Target
100 USD
Spread / Highest target
+79.76%
Low Price Target
65 USD
Spread / Lowest Target
+16.84%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Structure Therapeutics Inc.

JPMorgan Chase
Cantor Fitzgerald
JMP Securities
Piper Sandler
BMO Capital
Guggenheim
Jefferies & Co.
SVB Securities LLC

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. GPCR Stock
  4. Consensus Structure Therapeutics Inc.